Loading...

4,068 posters, 219 videos, 101 topics, 69 sessions, 14,365 authors, 6,128 institutions

ePostersLive by SciGen Technologies S.A. All rights reserved.

Alzheimer's Association International Conference 2026

July 12-15, 2026 | London, United Kingdom, and Online

Alzheimer's Association International Conference 2026 banner

5305

Reduced Cerebrovascular Reactivity In Mild Cognitive Impairment And Alzheimer's Disease Assessed By CO2 Challenge FMRI

Part of Topic

Background

Cerebrovascular reactivity (CVR) is the brain’s ability to regulate blood flow through dilation and and constriction of small arteriole vessels. Reduced CVR is a known hallmark of vascular disease and a risk factor for Alzheimer’s Disease (AD). Traditional CVR assessments in older adults use breath-holding or resting-state functional MRI, but these methods may fail to reach a vessel’s full dilatory capacity. Here, we employed a strong CO2 stimulus during functional MRI to map CVR. We investigated whether this robust measure of CVR serves as a marker of vascular impairment and subsequent cognitive deficits.

Objectives

1.Compare CVR in controls against individuals with Mild Cognitive Impairment (MCI) who are at risk of progressing to AD, and individuals with AD
2.Investigate relationship between CVR and global cognition measured by the Montreal Cognitive Assessment (MoCA)
 
Methods

Study Population

•13 cognitively normal (10F; 67±6 years)
•12 with MCI (7F; 71±6 years)
•4 with AD (4F, 73±6 years)
•MCI and AD were diagnosed at the University of Washington Alzheimer’s Disease Research Center Consensus Conference using UDS v3.0 and CDR, among other criteria (Controls: CDR = 0, MCI: CDR = 0.5, AD: CDR = 1)

Magnetic Resonance Imaging

•3D T1-weighted image
•8-minute functional MRI scan

Analysis

•CVR calculated as change in percent BOLD signal per change in end-tidal CO2 (mmHg)
•Average CVR in gray matter compared between groups with Wilcoxon rank sum
•Association between MoCA scores and CVR (adjusted for age and sex) evaluated with linear regression
 
Results

Cerebrovascular reactivity to a strong, dynamic CO2 stimulus was significantly lower in individuals with MCI or AD.

Figure 1: A) Example of the RespirActTM (Thornhill Medical) gas delivery system worn by participants during an 8-minute fMRI scan. B) Group average (Control vs. MCI/AD) blood-oxygenation-level dependent (BOLD) fMRI and end-tidal carbon dioxide (CO2) traces, shown as mean ± standard error. There were six stages of CO2 modulation: a 60-second baseline, 60-second hypercapnia (+10 mmHg), 60-second baseline, 60-second hypocapnia (-5 mmHg), 180-second ramp (-5 to +15 mmHg), and a final baseline.

Figure 2: Example CVR maps in an adult with Alzheimer’s disease and an age-matched, sex-matched control. CVR is the change in cerebral blood flow to a stimulus, reported here as the percent change in blood-oxygenation-level dependent (%BOLD) fMRI signal per change in CO2 pressure (in mmHg). Maps show only voxels with a significant fit (⍺ = 0.05) between CO2 and BOLD signals.

Figure 3: A) Comparison of CVR, averaged in gray matter. The lowest CVR value in the control group is an outlier based on Grubb’s test (G = 2.54, p=0.02) and was removed from statistical testing. B) Comparison of MoCA scores.

Discussion

Cerebrovascular Reactivity

•Deficit in MCI/AD appears to be impairment of vascular reaction speed, rather than lack of vasodilatory capacity. The normal response to the gradual ramp suggests vessels can still dilate fully when given ample time to adapt.
•Lower CVR in MCI/AD groups is consistent with previous studies and supports role of vascular dysfunction in disease progression
•CVR can be impaired even while resting cerebral perfusion is maintained, making it a potential early biomarker for cognitive decline

Association of CVR and MoCA Scores

•We did not observe a significant relationship between CVR and MoCA scores, although this has been reported in the literature
•This may be due to our sample size, or the nature of our CO2 stimulus

Future Work

•Explore association of CVR with executive function, a well-known impairment in individuals with cerebrovascular disease
•Explore relationship between CVR & markers of endothelial health (VEGF, E-selectin)
•Compare CVR delay (the timing of the blood flow response) between groups


 

 

Comments

Email is required but is not shown publicly.

Loading comments...

aaic2026 banner
Copyright © 2015-2026, ePostersLive® SciGen is a registered trademark of SciGen Technologies S.A. Patent pending.

This website and third-party tools we use rely on cookies for the best user experience. By selecting "I agree", you agree to cookie usage as described in our Privacy Policy.